In patients with grade II and III gliomas, both subtypes of ADK are increased in the tumor and peritumoral areas, in addition to the detection of tumor invasion in the peritumoral tissue suggesting that ADK is involved in glioma progression and ADK level elevations may be associated with epilepsy in glioma patients (Huang et al., 2015). This evidence concerns the gene ADK and epilepsy.